Steven Cohen Cytom X Therapeutics, Inc. Transaction History

Point72 Asset Management, L.P.

$40.1 Billion
Q1 2025

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 2,650,000 shares of CTMX stock, worth $6.89 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,650,000

Previous 2,650,000 -0.0%

Holding current value

$6.89 Million

Previous $2.73 Million 37.85%

% of portfolio

0.0%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$0.86 - $1.29 $2.28 Million - $3.42 Million	2,650,000 New	2,650,000 $2.73 Million
Q2 2022 Aug 15, 2022	SELL	$1.53 - $2.89 $2.48 Million - $4.69 Million	-1,621,300 Reduced 37.09%	2,750,000 $5.03 Million
Q1 2022 May 16, 2022	SELL	$2.67 - $4.68 $5.16 Million - $9.04 Million	-1,931,725 Reduced 30.65%	4,371,300 $11.7 Million
Q3 2021 Nov 15, 2021	SELL	$4.32 - $6.43 $392,580 - $584,326	-90,875 Reduced 1.42%	6,303,025 $32.1 Million
Q2 2021 Aug 16, 2021	BUY	$6.33 - $9.91 $372,837 - $583,699	58,900 Added 0.93%	6,393,900 $40.5 Million
Q1 2021 May 17, 2021	BUY	$6.6 - $9.0 $41 Million - $55.9 Million	6,210,000 Added 4968.0%	6,335,000 $49 Million
Q4 2020 Feb 16, 2021	BUY	$6.47 - $7.9 $808,750 - $987,500	125,000 New	125,000 $819,000
Q3 2020 Nov 16, 2020	SELL	$6.55 - $8.83 $6.77 Million - $9.12 Million	-1,033,406 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$7.4 - $14.64 $6.04 Million - $12 Million	816,842 Added 377.18%	1,033,406 $8.61 Million
Q1 2020 May 15, 2020	SELL	$3.61 - $8.6 $1.82 Million - $4.34 Million	-504,436 Reduced 69.96%	216,564 $1.66 Million
Q4 2019 Feb 14, 2020	BUY	$5.17 - $8.91 $3.73 Million - $6.42 Million	721,000 New	721,000 $5.99 Million
Q3 2019 Nov 15, 2019	SELL	$7.38 - $12.25 $2.44 Million - $4.05 Million	-330,498 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$9.35 - $11.41 $2.76 Million - $3.37 Million	-295,151 Reduced 47.18%	330,498 $3.71 Million
Q1 2019 May 15, 2019	SELL	$9.5 - $19.16 $7.96 Million - $16.1 Million	-838,147 Reduced 57.26%	625,649 $6.73 Million
Q4 2018 Feb 14, 2019	BUY	$12.69 - $18.61 $1.73 Million - $2.53 Million	136,056 Added 10.25%	1,463,796 $22.1 Million
Q3 2018 Nov 14, 2018	BUY	$18.04 - $26.41 $21.1 Million - $30.9 Million	1,169,569 Added 739.43%	1,327,740 $24.6 Million
Q2 2018 Aug 14, 2018	BUY	$21.38 - $29.68 $3.38 Million - $4.69 Million	158,171 New	158,171 $3.62 Million

Others Institutions Holding CTMX

# of Institutions

Shares Held

44.9M

Call Options Held

8.9K

Put Options Held

47.9K

View Full List

About CytomX Therapeutics, Inc.

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $171M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

More about CTMX

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account